URGN
UroGen Pharma Ltd.
$25.73
+$0.89(+3.58%)
63
Overall
40
Value
91
Tech
60
Quality
Market Cap
$1.10B
Volume
449.57K
52W Range
$3.42 - $25.19
Target Price
$34.88
EPS Estimates Overview
| Current Quarter | $-0.65 | Next Quarter | $-0.58 |
| Current Year | $-3.22 | Next Year | $-1.14 |
| QoQ Growth | +10.8% | YoY Growth | +64.6% |
| 3Y EPS CAGR | +15.8% | Target Price | $34.88 |
| Consensus | Buy | Upside | +35.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $25.73 | +3.6% | 449.57K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |